Idoroenyi Amanam to Antigens, CD19
This is a "connection" page, showing publications Idoroenyi Amanam has written about Antigens, CD19.
Connection Strength
0.230
-
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALL. Blood Adv. 2025 May 13; 9(9):2159-2172.
Score: 0.230